Haleon PLC ADR HLN
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HLN is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $8.47
- Day Range
- $8.31–8.44
- 52-Week Range
- $7.70–8.96
- Bid/Ask
- $8.38 / $8.48
- Market Cap
- $38.26 Bil
- Volume/Avg
- 4.1 Mil / 6.9 Mil
Key Statistics
- Price/Earnings (Normalized)
- 18.43
- Price/Sales
- 2.77
- Dividend Yield (Trailing)
- 1.80%
- Dividend Yield (Forward)
- 2.51%
- Total Yield
- 1.80%
Company Profile
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon’s brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Core
- Total Number of Employees
- 25,408
- Website
- https://www.haleon.com
Competitors
Valuation
|
Metric
|
HLN
|
RKT
|
PG
|
|---|---|---|---|
Price/Earnings (Normalized) | 18.43 | 9.90 | 25.21 |
Price/Book Value | 1.85 | 3.79 | 7.89 |
Price/Sales | 2.77 | 2.21 | 4.84 |
Price/Cash Flow | 17.50 | 11.92 | 20.08 |
Price/Earnings
HLN
RKT
PG
Financial Strength
|
Metric
|
HLN
|
RKT
|
PG
|
|---|---|---|---|
Quick Ratio | 0.63 | 0.40 | 0.40 |
Current Ratio | 1.04 | 0.64 | 0.64 |
Interest Coverage | 4.94 | 9.00 | 20.66 |
Quick Ratio
HLN
RKT
PG
Profitability
|
Metric
|
HLN
|
RKT
|
PG
|
|---|---|---|---|
Return on Assets (Normalized) | — | 8.60% | 13.82% |
Return on Equity (Normalized) | — | 26.61% | 35.61% |
Return on Invested Capital (Normalized) | — | 14.24% | 20.62% |
Return on Assets
HLN
RKT
PG
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Cxmppvklxm | Dhlcfv | $79.0 Bil | |
ZTS
| Zoetis Inc Class A | Kyjtxfsh | Ltz | $78.7 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Pbtylmqs | Pvlhx | $19.2 Bil | |
VTRS
| Viatris Inc | Wlkwtqr | Gggm | $12.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Wfkgfkc | Rkj | $11.5 Bil | |
CTLT
| Catalent Inc | Vjbsgxbpx | Zlssgx | $9.8 Bil | |
PRGO
| Perrigo Co PLC | Wngwflqn | Zmx | $3.8 Bil | |
CURLF
| Curaleaf Holdings Inc | Wdmzkbyf | Zjcyf | $3.3 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Wmkcwnxd | Rghfzq | $3.2 Bil |